Caption: Frontier Pharma: Schizophrenia and Associated Indications - Small but Diverse Range of First-in-Class Molecular Targets Hold Promise for Treatment of Negative and Cognitive Symptoms
Credit: Market Research Reports, Inc.
Frontier Pharma: Schizophrenia and Associated Indications; New Report Launched
Email & IM:
Source: Market Research Reports, Inc.
Release date: Wednesday May 25, 2016
Release time: 01:59 am
Size:: 396 KB